These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9055832)

  • 1. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
    J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
    Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
    Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA; Altshuler LL; Rasgon NL; Calcagno JL; Frye MA; Gitlin MJ; Hwang S; Zuckerbrow-Miller J
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are patients who are intolerant to one SSRI intolerant to another?
    Brown WA; Harrison W
    Psychopharmacol Bull; 1992; 28(3):253-6. PubMed ID: 1480728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
    Brown WA; Harrison W
    J Clin Psychiatry; 1995 Jan; 56(1):30-4. PubMed ID: 7836337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to an open trial of a second SSRI in major depression.
    Joffe RT; Levitt AJ; Sokolov ST; Young LT
    J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    Zarate CA; Kando JC; Tohen M; Weiss MK; Cole JO
    J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
    Boyer P; Danion JM; Bisserbe JC; Hotton JM; Troy S
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):157-69. PubMed ID: 10184835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
    Newhouse PA; Krishnan KR; Doraiswamy PM; Richter EM; Batzar ED; Clary CM
    J Clin Psychiatry; 2000 Aug; 61(8):559-68. PubMed ID: 10982198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP; Søgaard J; Roponen P; Behnke K
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial.
    Kafka MP
    Ann Clin Psychiatry; 1994 Sep; 6(3):189-95. PubMed ID: 7881500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram treatment of fluoxetine nonresponders.
    Thase ME; Feighner JP; Lydiard RB
    J Clin Psychiatry; 2001 Sep; 62(9):683-7. PubMed ID: 11681763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.